Target Audience: Typically, upper management at SMEs and biotech firms, including CEOs, CSOs and CFOs, those who know both the science and the business elements and may be responsible for vetting and hiring consultants as needed. In the case of a larger entity, it’s a mid- to top-management person at the business development, corporate development or project management level. Stakeholders: The typical SME/biotech firm is a small and lean organization. In the course of working on BD&L, almost everyone is a stakeholder, from the top management in all functional areas, to those working directly with the science, to those responsible for portfolio management, IP and out-licensing efforts, typically organized into teams. Since BD&L embodies the organization’s reason for being, almost all internal functions are ultimately oriented to that end, and all responsible parties have a role to play in the team effort. Industries Covered Organizations attempting to commercialize therapeutics, diagnostics, medical devices and medical foods. They can be start-up life sciences companies; commercial spin outs of academic research efforts; and even small and medium pharmaceutical firms. In rare cases, in-licensing for larger pharmaceutical firms. Target Company Size Typically,  small SMEs that are often not far removed from start-up mode, some of which can be as small as one- or two-person operations. On the top end, a client can be a multi-national with 10,000 employees, one looking for interim support in BD&L.